• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[人乳头瘤病毒整合与宫颈癌预后的关系]

[The relationship between HPV integration and prognosis of cervical cancer].

作者信息

Miao Z, Shen J, Zhang F Q, Hu K, Hou X R, Lian X, Sun S, Yan J F, Liu Z K

机构信息

Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2020 Dec 23;42(12):1014-1019. doi: 10.3760/cma.j.cn112152-20191031-00705.

DOI:10.3760/cma.j.cn112152-20191031-00705
PMID:33342157
Abstract

To investigate the relationship between human papillomavirus (HPV) integration and prognosis of cervical cancer patients. The data of 82 patients with cervical cancer treated in the Radiotherapy Department of Peking Union Medical College Hospital from October 2004 to June 2012 were retrospectively analyzed.The patients were divided into poor prognosis group (recurrence or metastasis after surgery and adjuvant radiotherapy) and good prognosis group based on a propensity score matching strategy.The HPV integration of the two groups were detected by whole exome sequencing to determine whether the integration sites were located in the common fragile sites (CFSs). HPV integration and integration into CFSs were compared between the two groups. Among the enrolled 82 patients, 37 were divided in poor survival group and 45 in good survival group. A total of 90 integration breakpoints were identified, 30 of them occurred in poor prognosis group and 60 occurred in good prognosis group. In the poor prognosis group, HPV integration occurred in 20 patients, 13 of them were inserted in CFSs of 11 patients, and the numbers in good prognosis group were 26, 17, 11, respectively. There were no significantly statistical differences in the number of HPV integration events (=0.289), HPV integration patients (=0.735), CFSs integration events (=0.427), and CFSs integration patients (=0.591) between the two groups. In poor prognosis group, more CFSs integration events occurred in patients with metastasis than those in patients with only local recurrence (9 vs 2, =0.003). No significant differences are observed in HPV integration and HPV integration into CFSs between cervical cancer patients with different prognoses. HPV integration into CFSs may be associated with distant metastasis.

摘要

探讨人乳头瘤病毒(HPV)整合与宫颈癌患者预后的关系。回顾性分析2004年10月至2012年6月在北京协和医院放疗科接受治疗的82例宫颈癌患者的数据。采用倾向评分匹配策略将患者分为预后不良组(手术及辅助放疗后复发或转移)和预后良好组。通过全外显子测序检测两组患者的HPV整合情况,以确定整合位点是否位于常见脆性位点(CFSs)。比较两组之间HPV整合及整合入CFSs的情况。在纳入的82例患者中,37例分为生存不良组,45例分为生存良好组。共鉴定出90个整合断点,其中30个发生在预后不良组,60个发生在预后良好组。在预后不良组中,20例患者发生HPV整合,其中13例插入11例患者的CFSs中,在预后良好组中的相应数字分别为26、17、11。两组之间HPV整合事件数量(=0.289)、HPV整合患者数量(=0.735)、CFSs整合事件数量(=0.427)及CFSs整合患者数量(=0.591)均无显著统计学差异。在预后不良组中,发生转移的患者比仅局部复发的患者发生更多CFSs整合事件(9比2,=0.003)。不同预后的宫颈癌患者在HPV整合及HPV整合入CFSs方面未观察到显著差异。HPV整合入CFSs可能与远处转移有关。

相似文献

1
[The relationship between HPV integration and prognosis of cervical cancer].[人乳头瘤病毒整合与宫颈癌预后的关系]
Zhonghua Zhong Liu Za Zhi. 2020 Dec 23;42(12):1014-1019. doi: 10.3760/cma.j.cn112152-20191031-00705.
2
Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma.人乳头瘤病毒18型在宫颈癌中优先整合于c-myc基因座附近。
Oncogene. 2003 Oct 16;22(46):7233-42. doi: 10.1038/sj.onc.1207006.
3
Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.利用人乳头瘤病毒(HPV)捕获技术对宫颈癌中人乳头瘤病毒(HPV)DNA整合位点进行全面定位。
Oncotarget. 2016 Feb 2;7(5):5852-64. doi: 10.18632/oncotarget.6809.
4
Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.高级别宫颈癌前病变中16型人乳头瘤病毒整合位点的鉴定
Gynecol Oncol. 2009 Apr;113(1):120-7. doi: 10.1016/j.ygyno.2008.12.004. Epub 2009 Jan 21.
5
Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites.16型人乳头瘤病毒在宫颈肿瘤中的整合经常发生在常见易碎位点。
Cancer Res. 2000 Nov 1;60(21):5916-21.
6
Common fragile sites are preferential targets for HPV16 integrations in cervical tumors.常见脆性位点是宫颈癌中HPV16整合的优先靶点。
Oncogene. 2003 Feb 27;22(8):1225-37. doi: 10.1038/sj.onc.1206170.
7
Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.人乳头瘤病毒基因组在宫颈病变中的类型依赖性整合频率
Cancer Res. 2008 Jan 1;68(1):307-13. doi: 10.1158/0008-5472.CAN-07-2754.
8
Independent prognostic role of human papillomavirus genotype in cervical cancer.人乳头瘤病毒基因型在宫颈癌中的独立预后作用。
BMC Infect Dis. 2017 Jun 5;17(1):391. doi: 10.1186/s12879-017-2465-y.
9
Mate pair sequencing of oropharyngeal squamous cell carcinomas reveals that HPV integration occurs much less frequently than in cervical cancer.口咽鳞状细胞癌的 Mate 对测序显示,HPV 整合的频率远低于宫颈癌。
J Clin Virol. 2014 Mar;59(3):195-200. doi: 10.1016/j.jcv.2013.12.006. Epub 2013 Dec 28.
10
Common fragile sites (CFS) and extremely large CFS genes are targets for human papillomavirus integrations and chromosome rearrangements in oropharyngeal squamous cell carcinoma.常见脆性位点(CFS)和极大的CFS基因是口咽鳞状细胞癌中人乳头瘤病毒整合和染色体重排的靶点。
Genes Chromosomes Cancer. 2017 Jan;56(1):59-74. doi: 10.1002/gcc.22415. Epub 2016 Nov 1.

引用本文的文献

1
The Relationship between Systemic Expression Levels of Immune Cells and Tumor Markers and High-Risk HPV Infection in Patients with Cervical Cancer, Cervical Intraepithelial Neoplasia, and Chronic Cervicitis, and its Clinical Significance.宫颈癌、宫颈上皮内瘤变及慢性宫颈炎患者免疫细胞和肿瘤标志物的全身表达水平与高危型人乳头瘤病毒感染的关系及其临床意义
Int J Womens Health. 2025 May 6;17:1263-1270. doi: 10.2147/IJWH.S515393. eCollection 2025.
2
Risk of residual/recurrent cervical diseases in HPV-positive women post-conization depends on HPV integration status.锥切术后HPV阳性女性残留/复发性宫颈疾病的风险取决于HPV整合状态。
Infect Agent Cancer. 2025 Jan 28;20(1):5. doi: 10.1186/s13027-025-00637-3.
3
Cervical cancer heterogeneity: a constant battle against viruses and drugs.
宫颈癌异质性:与病毒和药物的持续斗争。
Biomark Res. 2022 Nov 17;10(1):85. doi: 10.1186/s40364-022-00428-7.
4
The diagnostic accuracy of TCT + HPV-DNA for cervical cancer: systematic review and meta-analysis.TCT + HPV-DNA检测对宫颈癌的诊断准确性:系统评价与Meta分析
Ann Transl Med. 2022 Jul;10(14):761. doi: 10.21037/atm-22-1732.